Metraipolis › archive › dc_99c605bb2e07

CAR-T cell therapy in cancer immunotherapy - Biology, clinical successes, and emerging challenges: A review — Europe PMC PMID:42189068

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42189068
DOI
10.17305/bb.2026.14266
License (as archived)
solo-consultazione
Archived
2026-11-01T07:40:48.816Z
SHA-256 of the archived text
fdbd1f065c9c8e7fae08fe077d6101cb27d59deea399f5baf16aadd8e1c40e9c
Stable URL of this page
https://metraipolis.com/documento/dc_99c605bb2e07

How to cite

CAR-T cell therapy in cancer immunotherapy - Biology, clinical successes, and emerging challenges: A review — Europe PMC PMID:42189068 — Europe PMC (en), https://europepmc.org/article/MED/42189068 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99c605bb2e07 (Metraipolis archive dc_99c605bb2e07, sha256 fdbd1f065c9c8e7fae08fe077d6101cb27d59deea399f5baf16aadd8e1c40e9c)
BibTeX
@misc{dc99c605bb2e07,
  title = {CAR-T cell therapy in cancer immunotherapy - Biology, clinical successes, and emerging challenges: A review — Europe PMC PMID:42189068},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42189068},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99c605bb2e07; sha256 fdbd1f065c9c8e7fae08fe077d6101cb27d59deea399f5baf16aadd8e1c40e9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42189068. Agents can read the archived copy with the MCP tool read_document.